Angiodysplasia overview: Difference between revisions

Jump to navigation Jump to search
Line 20: Line 20:


==Risk Factors==
==Risk Factors==
The most important risk factors for angiodysplasia include:  
The most important [https://www.wikidoc.org/index.php/Risk%20factors risk factors] for active bleeding from angiodysplasia include advanced age, cardiovascular [https://www.wikidoc.org/index.php/Comorbidities comorbidities], [https://www.wikidoc.org/index.php/Von%20Willebrand%20disease von Willebrand disease,] [https://www.wikidoc.org/index.php/End-stage%20renal%20disease end-stage renal disease,] and [https://www.wikidoc.org/index.php/Antiplatelet%20drug antiplatelet] or [https://www.wikidoc.org/index.php/Anticoagulants anticoagulant] use.
 
Age (>60 years)
 
[[Aortic stenosis]]  
 
[[von Willebrand disease]] (VWD)
 
[[Chronic kidney disease]]  
 
==Screening==
==Screening==
There are no specific indications for screening angiodysplasia.
There are no specific indications for screening angiodysplasia.

Revision as of 16:59, 13 September 2021

Angiodysplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angiodysplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Angiodysplasia overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angiodysplasia overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angiodysplasia overview

CDC on Angiodysplasia overview

Angiodysplasia overview in the news

Blogs on Angiodysplasia overview

Directions to Hospitals Treating Angiodysplasia

Risk calculators and risk factors for Angiodysplasia overview

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nikita Singh, M.D.[2]

Overview

Historical Perspective

Angiodysplasia was first reported in 1839 by Phillips as a vascular lesion causing bleeding from large intestine. Heyde discovered the association between aortic stenosis and angiodysplasia in 1958. The term angiodysplasia was coined by Galdabini in 1974.

Classification

There are multiple systems of classification of angiodysplasia. One system of classification is based on location, size, and number of angiodysplastic lesions. Another system uses endoscopic findings to classify angiodysplasia.

Pathophysiology

The exact pathogenesis of angiodysplasia is unknown. It has been proposed that chronic obstruction of submucosal veins coupled with the effect of ageing, ultimately leading to the formation of small arterio-venous collaterals. Angiogenic factors have also been found to play a role in the development of angiodysplasia.

Differentiating Angiodysplasia overview from Other Diseases

Angiodysplasia must be differentiated from other diseases that cause hematochezia, melena, and iron deficiency anemia like, diverticulitis, hemorrhoids, colon cancer, upper GI bleed and inflammatory bowel disease.

Epidemiology and Demographics

Angiodysplasia is the most common vascular malformation of the GI tract and accounts for 20% of major episodes of lower intestinal bleeding. The prevalence of angiodysplasia is less than 1% in healthy patients older than 50 years undergoing screening colonoscopy. The incidence of angiodysplasia is equal in both men and women. Majority of the affected population is older than 60 years. The most common location of angiodysplasia of the gastrointestinal tract is the colon.

Risk Factors

The most important risk factors for active bleeding from angiodysplasia include advanced age, cardiovascular comorbidities, von Willebrand disease, end-stage renal disease, and antiplatelet or anticoagulant use.

Screening

There are no specific indications for screening angiodysplasia.

Natural History, Complications, and Prognosis

Natural History

The natural history of angiodysplasia in asymptomatic people is benign and the risk of bleeding is low.

Complications

Anemia, hemodynamic instability from massive blood loss.

Prognosis

Prognosis is favorable in asymptomatic cases and in cases where bleeding is controlled.

Diagnosis

Diagnostic Criteria

History and Symptoms

Many patients with angiodysplasia lack symptoms. Others present with GI bleeding or its consequences. Patients may present with rectal bleeding (0-60%), melena (passing black tarry bloody stool) (0-26%), occult blood positive stool (4-47%), or iron deficiency anemia (0-51%). Spontaneous cessation of bleeding (90%) is the rule for lesions located in any part of the GI tract.

Symptoms include hematochezia ( 60%), melena ( 26%), hematemesis observed in angiodysplasia of the upper GI tract.

Physical Examination

Signs and symptoms of iron deficiency anemia like can be found in patients with occult bleeding.

A systolic ejection murmur can be heard if associated with aortic stenosis.

Laboratory Findings

Complete blood count, renal function tests, liver function tests and coagulation studies to diagnose any underlying medical conditions.

Imaging Findings

Endoscopy is the imaging modality of choice for the diagnosis of angiodysplasia. Lesions appear like flat, 5- to 10 mm, cherry-red, fern-like pattern of vessels.

Other Diagnostic Studies

Hdelical CT angiography or magnetic resonance angiography can be used in case the conventional methods fail to show bleeding sources.

Treatment

Medical Therapy

Endoscopic treatment is the therapy of choice in which cautery or argon plasma coagulation (APC) is used. Other options are mechanical hemostasis using clips, sclerotherapy. First-line medications are antifibrinolytics tranexamic acid or aminocaproic acid. Estrogens can be used to stop bleeding from angiodysplasia. In difficult cases, there have been positive reports about octreotide and thalidomide,

Surgery

In severe cases or cases not responsive to either endoscopic or medical treatment, surgical resection may be necessary to arrest the bleeding.

Prevention

Primary or secondary prevention is currently not available.

References

Template:WS Template:WH